Court of Appeals for the Federal Circuit January 31, 2012, No. 2011-1611 (Warner Chilcott Laboratories Ireland Ltd. v. Mylan Pharmaceuticals Inc.)
Also known as
United States · · · 31-01-2012
O’MALLEY, Circuit Judge.
This is a Hatch-Waxman Act case in which Mylan Pharmaceuticals Inc. and Mylan Inc. (collectively, “Mylan”) appeal the district court’s entry of a preliminary injunction prohibiting Mylan from launching the generic version of 150 mg Doryx, which is the branded name for the doxycy-cline hyclate delayed-release tablets sold by Plaintiffs-Appellees.
Read the full text
This document is published by courtlistener.com.
Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.
Sign in to Moonlit